7-(5-methoxy-2-((4-methylpyridin-2-yl)methoxy)phenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine

ID: ALA4281286

PubChem CID: 70665128

Max Phase: Preclinical

Molecular Formula: C24H26N2O2

Molecular Weight: 374.48

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(OCc2cc(C)ccn2)c(-c2ccc3c(c2)CCNCC3)c1

Standard InChI:  InChI=1S/C24H26N2O2/c1-17-7-12-26-21(13-17)16-28-24-6-5-22(27-2)15-23(24)20-4-3-18-8-10-25-11-9-19(18)14-20/h3-7,12-15,25H,8-11,16H2,1-2H3

Standard InChI Key:  NEKARSRXGYDKMG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   10.4570  -14.3049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4558  -15.1245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1639  -15.5334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8735  -15.1240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8707  -14.3013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1621  -13.8961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5819  -15.5315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2890  -15.1218    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.9973  -15.5293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9940  -16.3449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7015  -16.7523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4095  -16.3425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4056  -15.5211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6975  -15.1174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6892  -14.3025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3957  -13.8897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9723  -13.0864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9810  -13.9015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3883  -13.0722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6806  -12.6703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5499  -11.8614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1481  -12.7654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0964  -11.2551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3811  -11.9804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9110  -11.3103    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1596  -13.0789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1184  -16.7491    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1208  -17.5663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 15 16  2  0
 16 19  1  0
 20 17  1  0
 17 18  2  0
 18 15  1  0
 14 15  1  0
 19 20  2  0
 20 21  1  0
 19 22  1  0
 21 23  1  0
 22 24  1  0
 23 25  1  0
 24 25  1  0
  6 26  1  0
 12 27  1  0
 27 28  1  0
M  END

Associated Targets(Human)

SYK Tclin Tyrosine-protein kinase SYK (7372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKB Tchem Aurora kinase B/Inner centromere protein (233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 374.48Molecular Weight (Monoisotopic): 374.1994AlogP: 4.33#Rotatable Bonds: 5
Polar Surface Area: 43.38Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.02CX LogP: 4.29CX LogD: 1.76
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.72Np Likeness Score: -0.59

References

1. Barker MD, Liddle J, Atkinson FL, Wilson DM, Dickson MC, Ramirez-Molina C, Lewis H, Davis RP, Somers DO, Neu M, Jones E, Watson R..  (2018)  Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease.,  28  (21): [PMID:30249354] [10.1016/j.bmcl.2018.09.022]

Source